Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.
Sharib J, Rhodin KE, Liu A, McIntyre S, Bartholomew A, Masoud S, DeLaura I, Kemeny NE, Cercek A, Harding JJ, O'Reilly EM, Abou-Alfa GK, Reidy-Lagunes D, Connell LC, Dika IE, Balachandran VP, Drebin J, Soares KC, Wei AC, Kingham TP, D'Angelica MI, Uronis H, Strickler J, Hsu SD, Morse M, Zani S, Allen PJ, Jarnagin WR, Lidsky ME.
Sharib J, et al. Among authors: wei ac.
Ann Surg Oncol. 2025 Jan 18. doi: 10.1245/s10434-024-16799-0. Online ahead of print.
Ann Surg Oncol. 2025.
PMID: 39827317